Genenta Science S.p.A. (GNTA) Income Statement

NASDAQ: GNTARevenue, profits, margins and EPS over 7 years.

GNTA 2025 at a glance

Fiscal year ended December 31, 2025 · euros
Research & development−48.4%
€2.6M
2025 · hover or tap a bar for each year
2019: €3.7M2020: €4.4M (+19.5%)2021: €3.5M (−19.0%)2022: €5.2M (+47.5%)2023: €6.4M (+22.0%)2024: €5.0M (−21.0%)2025: €2.6M (−48.4%)
20192025
Operating expenses−37.8%
€6.3M
2025 · hover or tap a bar for each year
2019: €4.6M2020: €5.2M (+14.1%)2021: €5.9M (+13.9%)2022: €10.8M (+82.0%)2023: €11.5M (+6.5%)2024: €10.2M (−11.6%)2025: €6.3M (−37.8%)
20192025
Operating income
−€6.3M
2025 · hover or tap a bar for each year
2019: −€4.6M2020: −€5.2M2021: −€5.9M2022: −€10.8M2023: −€11.5M2024: −€10.2M2025: −€6.3M
20192025
Net income
−€6.3M
2025 · hover or tap a bar for each year
2019: −€4.5M2020: −€5.2M2021: −€5.8M2022: −€8.3M2023: −€11.4M2024: −€9.3M2025: −€6.3M
20192025

GNTA revenue and net income

RevenueNet incomeNet margin (right axis)

GNTA growth rates

to 2025
1 year3 years5 years10 years
Revenue————
Gross profit————
Operating income————
Net income————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

GNTA income statement in euros

Genenta Science S.p.A. annual income statement
2025202420232022202120202019
Revenue€0€0€0€0€0€0€0
Cost of revenue€26,973€46,508€41,705€5,996€5,096€1,768—
Gross profit−€26,973−€46,508−€41,705−€5,996−€5,096−€1,768—
Research & development€2.6M€5.0M€6.4M€5.2M€3.5M€4.4M€3.7M
Sales, general & admin€3.9M€5.0M€5.3M€5.7M€2.3M€901,765€921,520
Total operating expenses€6.3M€10.2M€11.5M€10.8M€5.9M€5.2M€4.6M
Operating income−€6.3M−€10.2M−€11.5M−€10.8M−€5.9M−€5.2M−€4.6M
Interest income€608,508€81,140€309,253€36,985€11,716——
Interest expense€384,212——€2.6M€11,716€7,754€9,552
Income before taxes−€6.3M−€9.3M−€11.4M−€8.3M−€5.8M−€5.2M−€4.5M
Income taxes——€4−€4.9M€31,373€13,720€9,552
Net income−€6.3M−€9.3M−€11.4M−€8.3M−€5.8M−€5.2M−€4.5M
EBITDA−€5.9M−€9.3M−€11.4M−€8.3M−€5.8M−€5.2M−€4.6M

Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported in GNTA's financial statements (latest annual report filed April 1, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

GNTA financial results

Genenta Science S.p.A. reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of €6.3 million. Figures are in euros, the currency of its financial statements.

See the GNTA stock overview for the latest quote and news, or the GNTA chart for price history and technical indicators.

GNTA income statement FAQ

Does Genenta Science S.p.A. have revenue?

Genenta Science S.p.A. reported no revenue for fiscal year 2025, which ended on December 31, 2025.

Is Genenta Science S.p.A. profitable?

No. Genenta Science S.p.A. reported a net loss of €6.3 million in fiscal 2025.

How much does Genenta Science S.p.A. spend on research and development?

Genenta Science S.p.A. spent €2.6 million on research and development in fiscal 2025.

When does Genenta Science S.p.A.'s fiscal year end?

Genenta Science S.p.A.'s fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 1, 2026.

Conglomerates income statements